Catalyst Pharmaceuticals
CPRX
#3987
Rank
HK$22.51 B
Marketcap
HK$183.17
Share price
1.95%
Change (1 day)
8.48%
Change (1 year)

Catalyst Pharmaceuticals (CPRX) - Cash on Hand

Cash on Hand as of September 2025 : HK$5.37 Billion

According to Catalyst Pharmaceuticals's latest financial reports the company has HK$5.37 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Catalyst Pharmaceuticals - Cash on Hand chart (from 2004 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$4.01 B273.79%
2023-12-31HK$1.07 B-53.89%
2022-12-31HK$2.33 B56.32%
2021-12-31HK$1.49 B37.15%
2020-12-31HK$1.08 B47.73%
2019-12-31HK$0.73 B75.77%
2018-12-31HK$0.41 B-36.2%
2017-12-31HK$0.65 B109.49%
2016-12-31HK$0.31 B-30.77%
2015-12-31HK$0.45 B48.58%
2014-12-31HK$0.30 B65.69%
2013-12-31HK$0.18 B53.86%
2012-12-31HK$0.11 B155.2%
2011-12-31HK$46.82 M9.9%
2010-12-31HK$42.6 M-29.36%
2009-12-31HK$60.31 M-33.66%
2008-12-31HK$90.92 M-26.86%
2007-12-31HK$0.12 B-21.78%
2006-12-31HK$0.15 B2558.25%
2005-12-31HK$5.97 M318.33%
2004-12-31HK$1.42 M
2002-12-31HK$0.83 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
BioMarin Pharmaceutical
BMRN
HK$11.50 B 114.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$6.62 B 23.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$144.49 B 2,590.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
HK$72.89 M-98.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$116.64 B 2,071.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$60.19 B 1,020.90%๐Ÿ‡บ๐Ÿ‡ธ USA